Takeda Pharmaceutical
TAK
#491
Rank
A$71.42 B
Marketcap
A$21.46
Share price
0.28%
Change (1 day)
2.28%
Change (1 year)

Takeda Pharmaceutical (TAK) - Cash on Hand

Cash on Hand as of September 2025 : A$7.54 Billion

According to Takeda Pharmaceutical's latest financial reports the company has A$7.54 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Takeda Pharmaceutical - Cash on Hand chart (from 2008 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2025-03-31A$4.33 B-9.34%
2024-03-31A$4.78 B-22.89%
2023-03-31A$6.20 B-35.36%
2022-03-31A$9.59 B-19.55%
2021-03-31A$11.92 B20.39%
2020-03-31A$9.90 B7.81%
2019-03-31A$9.18 B100%
2018-03-31A$4.59 B3.89%
2017-03-31A$4.42 B-31.89%
2016-03-31A$6.49 B-16.85%
2015-03-31A$7.80 B-12.24%
2014-03-31A$8.89 B55.44%
2013-03-31A$5.72 B6.9%
2012-03-31A$5.35 B-47.25%
2011-03-31A$10.14 B-0.72%
2010-03-31A$10.22 B-7.09%
2009-03-31A$11.00 B-38.48%
2008-03-31A$17.88 B-5.46%
2007-03-31A$18.91 B-15.86%
2006-03-31A$22.48 B22.89%
2005-03-31A$18.29 B8.52%
2004-03-31A$16.85 B4.96%
2003-03-31A$16.06 B28.92%
2002-03-31A$12.45 B5.41%
2001-03-31A$11.81 B

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Johnson & Johnson
JNJ
A$28.01 B 271.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
A$15.77 B 109.12%๐Ÿ‡ซ๐Ÿ‡ท France
Pfizer
PFE
A$22.61 B 199.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
A$14.72 B 95.14%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Seagen
SGEN
A$1.86 B-75.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Dr. Reddy's Laboratories
RDY
A$1.18 B-84.28%๐Ÿ‡ฎ๐Ÿ‡ณ India
Amgen
AMGN
A$14.25 B 88.98%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
A$6.70 B-11.08%๐Ÿ‡ฌ๐Ÿ‡ง UK
Merck
MRK
A$27.49 B 264.43%๐Ÿ‡บ๐Ÿ‡ธ USA